Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Study to Design a Tailored Precision Nutrition Strategy Based on Metabotypes in the Elderly
Authors not listed
Fundació Eurecat · 2022
Abstract
From a public health point of view, personalized nutritional recommendations, at the individual level, are difficult to achieve in the short-medium term, especially in population segments with less purchasing power. Therefore, a more realistic vision in the short term and with a more favourable cost/effectiveness ratio consists of carrying out dietary advice at the group level through the identification of metabotypes, which can be defined as groups of individuals with similar metabolic profiles. The application of tailored precision nutrition aimed at the elderly is detected as a strategy to understand the different alterations associated to aging and to design innovative nutritional interventions that address this physiological process, favouring a healthy ageing.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2022). Study to Design a Tailored Precision Nutrition Strategy Based on Metabotypes in the Elderly. <em>Fundació Eurecat</em>. https://clinicaltrials.gov/study/NCT05566938
Vancouver
Anonymous. Study to Design a Tailored Precision Nutrition Strategy Based on Metabotypes in the Elderly. Fundació Eurecat. 2022.
BibTeX
@misc{anon2022Studyt,
title = {Study to Design a Tailored Precision Nutrition Strategy Based on Metabotypes in the Elderly},
author = {Anonymous},
journal = {Fundació Eurecat},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroinflammation 2008
Open access · CC-BY
Inflammaging as a prodrome to Alzheimer's disease
Elsevier eBooks 2019
Citation only
Inflammaging Targets
University of Cincinnati 2016
Open access · US-GOV
Early Intervention in Cognitive Aging
Immunity & Ageing 2022
Open access · CC-BY
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
Clinica Universidad de Navarra, Universidad de Navarra 2021
Open access · US-GOV
Study of the Efficacy of a New Nutritional Supplement, Compared with Placebo, in Promoting Active and Healthy Aging from the Age of 65
Hillel Yaffe Medical Center 2013
Open access · US-GOV